Tonix Pharmaceuticals Holding Corp. (TNXP) Social Stream



Tonix Pharmaceuticals Holding Corp. (TNXP): $0.19

0.14 (-43.10%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add TNXP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#179 of 344

in industry

TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TNXP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-31 1 $2 $1.5 $1.75 $0.282 520.57%
2022-04-19 1 $2 $0.6 $1.366 $0.282 384.4%
2022-05-25 1 $63.897 $10 $40.606 $0.282 14299.29%
2022-05-31 1 $63.897 $10 $29.965 $0.282 10525.89%
2022-09-12 1 $10 $8 $9 $0.282 3091.49%
2022-12-05 1 $10 $6 $8 $0.282 2736.88%
2023-01-12 1 $10 $6 $7.5 $0.282 2559.57%
2023-04-14 1 $6.5 $6 $6.333 $0.282 2145.74%
2023-05-09 1 $40.625 $40.625 $40.625 $0.282 14306.03%
2023-05-30 1 $40.625 $6.5 $29.25 $0.282 10272.34%
2023-06-02 1 $40.625 $6.5 $21.708 $0.282 7597.87%
2023-06-21 1 $18 $6.5 $12.833 $0.282 4450.71%
2023-06-27 1 $18 $10 $14 $0.282 4864.54%
2023-07-06 1 $18 $10 $14.333 $0.282 4982.62%
2023-07-25 1 $18 $6.5 $13.166 $0.282 4568.79%
2023-08-01 1 $15 $6.5 $9.833 $0.282 3386.88%
2023-09-06 1 $15 $8 $11 $0.282 3800.71%
2023-09-26 1 $10 $8 $8.666 $0.282 2973.05%
2023-12-21 1 $10 $3 $7 $0.282 2382.27%
2023-12-22 1 $10 $3 $6.333 $0.282 2145.74%

Price Target Last Issued September 26, 2023

The Trend in the Analyst Price Target


TNXP's average price target has moved up $2.08 over the prior 29 months.

Over the past 49 weeks, TNXP's average upside potential has been 1,553.69%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-01 1 6.500 6.5 6.500 3.00 116.67%
2023-05-01 1 6.500 6.5 6.500 0.48 1254.17%
2023-05-30 1 40.625 6.5 29.250 1.63 1694.48%
2023-07-06 1 18.000 10.0 14.333 1.55 824.71%
2023-09-06 1 15.000 8.0 11.000 0.92 1095.65%

TNXP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 52 weeks, TNXP's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TNXP as an investment opportunity.

  • In terms of how TONIX PHARMACEUTICALS HOLDING CORP fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
  • In the context of all US stocks, TONIX PHARMACEUTICALS HOLDING CORP's upside potential (average analyst target price relative to current price) is higher than 2276.04% of them.
  • TONIX PHARMACEUTICALS HOLDING CORP's variance in analysts' estimates is lower than -1336.78% of stocks in the small market cap category.
  • TNXP has a higher average analyst price target than 551.53% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TONIX PHARMACEUTICALS HOLDING CORP are FBIO, ASMB, and KURA.

What is the outlook for TNXP? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!